Benefits and risks of anthracyclines in early-stage breast cancer - Authors' reply.

Braybrooke J., Bradley R., Gray R., Hills R., Early Breast Cancer Trialists' Collaborative Group None.

DOI

10.1016/S0140-6736(23)02890-8

Type

Journal article

Journal

Lancet

Publication Date

30/03/2024

Volume

403

Keywords

Humans, Female, Breast Neoplasms, Anthracyclines, Antibiotics, Antineoplastic, Taxoids, Risk Assessment

Permalink Original publication